Man Group plc Purchases Shares of 139,095 Revvity, Inc. (NYSE:RVTY)

Man Group plc bought a new stake in shares of Revvity, Inc. (NYSE:RVTY - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 139,095 shares of the company's stock, valued at approximately $15,524,000. Man Group plc owned approximately 0.11% of Revvity at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Oak Thistle LLC bought a new position in shares of Revvity in the fourth quarter worth about $317,000. RDA Financial Network grew its holdings in shares of Revvity by 5.1% in the fourth quarter. RDA Financial Network now owns 3,216 shares of the company's stock worth $359,000 after purchasing an additional 157 shares during the last quarter. Avanza Fonder AB purchased a new position in shares of Revvity during the fourth quarter valued at $898,000. HB Wealth Management LLC increased its holdings in shares of Revvity by 4.6% in the 4th quarter. HB Wealth Management LLC now owns 2,380 shares of the company's stock valued at $266,000 after acquiring an additional 104 shares during the period. Finally, Guinness Asset Management LTD grew its holdings in Revvity by 18.1% in the fourth quarter. Guinness Asset Management LTD now owns 4,564 shares of the company's stock worth $509,000 after purchasing an additional 701 shares during the last quarter. Institutional investors own 86.65% of the company's stock.

Revvity Stock Performance

Shares of NYSE:RVTY traded down $0.91 during mid-day trading on Tuesday, reaching $93.39. The company had a trading volume of 1,072,766 shares, compared to its average volume of 948,352. The firm has a market cap of $11.01 billion, a price-to-earnings ratio of 42.26, a PEG ratio of 3.82 and a beta of 1.02. Revvity, Inc. has a one year low of $88.53 and a one year high of $129.50. The company has a current ratio of 3.60, a quick ratio of 3.03 and a debt-to-equity ratio of 0.41. The company's 50-day moving average price is $98.41 and its 200-day moving average price is $110.06.

Revvity (NYSE:RVTY - Get Free Report) last posted its quarterly earnings data on Monday, April 28th. The company reported $1.01 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. The firm had revenue of $664.76 million for the quarter, compared to analysts' expectations of $662.30 million. During the same quarter last year, the company posted $0.98 EPS. The business's quarterly revenue was up 2.3% on a year-over-year basis. As a group, equities research analysts anticipate that Revvity, Inc. will post 4.94 EPS for the current fiscal year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 8th. Investors of record on Friday, July 18th will be issued a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.30%. The ex-dividend date is Friday, July 18th. Revvity's payout ratio is currently 11.91%.

Analysts Set New Price Targets

RVTY has been the subject of a number of analyst reports. KeyCorp upped their price objective on shares of Revvity from $132.00 to $145.00 and gave the stock an "overweight" rating in a research report on Monday, February 3rd. The Goldman Sachs Group dropped their price objective on Revvity from $140.00 to $125.00 and set a "buy" rating for the company in a research note on Tuesday, April 29th. JPMorgan Chase & Co. cut their price target on Revvity from $120.00 to $100.00 and set a "neutral" rating on the stock in a report on Tuesday, April 29th. Wells Fargo & Company decreased their price target on Revvity from $130.00 to $102.00 and set an "equal weight" rating for the company in a report on Thursday, April 17th. Finally, Raymond James reiterated an "outperform" rating and set a $120.00 price target (down from $145.00) on shares of Revvity in a research note on Tuesday, April 29th. Four investment analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, Revvity currently has a consensus rating of "Moderate Buy" and a consensus target price of $125.64.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.